Diagnostic and prognostic role of biomarkers for pulmonary hypertension in interstitial lung disease

作者: Charlotte U. Andersen , Søren Mellemkjær , Jens Erik Nielsen-Kudsk , Elisabeth Bendstrup , Ulf Simonsen

DOI: 10.1016/J.RMED.2012.09.003

关键词:

摘要: Summary Background Pulmonary hypertension (PH) is an important complication to interstitial lung disease (ILD). The aim of the present study was investigate relation NT-proBNP, fibrin D-dimer, troponin-T, uric acid and exhaled nitric oxide (NO) presence PH mortality in ILD. Methods In a previously described cohort 212 ILD patients whom 29 had PH, levels above mentioned biomarkers were analyzed as routine tests. Results A value NT-proBNP below 95 ng/l negative predictive for 99% (95% CI: 94–100). Values troponin-T higher with (median (inter quartile range) = 9 (9–20) vs. 9(9–10) ng/l), odds ratio (OR) increased abnormal (OR CI) = 3.1(1.1–8.8)). values 50 th percentile, D-dimer 90th percentile each associated mortality. Conclusions may be used rule-out test ILD, while risk factor PH. have prognostic patients, NO do not seem predict or

参考文章(21)
D. Bonderman, P. Wexberg, A. M. Martischnig, H. Heinzl, M.-B. Lang, R. Sadushi, N. Skoro-Sajer, I. M. Lang, A noninvasive algorithm to exclude pre-capillary pulmonary hypertension. European Respiratory Journal. ,vol. 37, pp. 1096- 1103 ,(2011) , 10.1183/09031936.00089610
Charlotte U. Andersen, Søren Mellemkjær, Ole Hilberg, Jens Erik Nielsen-Kudsk, Ulf Simonsen, Elisabeth Bendstrup, Pulmonary hypertension in interstitial lung disease: Prevalence, prognosis and 6 min walk test Respiratory Medicine. ,vol. 106, pp. 875- 882 ,(2012) , 10.1016/J.RMED.2012.02.015
Selim M. Arcasoy, Jason D. Christie, Victor A. Ferrari, Martin St. John Sutton, David A. Zisman, Nancy P. Blumenthal, Alberto Pochettino, Robert M. Kotloff, Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. American Journal of Respiratory and Critical Care Medicine. ,vol. 167, pp. 735- 740 ,(2003) , 10.1164/RCCM.200210-1130OC
Charlotte U. Andersen, Søren Mellemkjær, Jens E. Nielsen-Kudsk, Lene D. Sønderskov, Britt E. Laursen, Ulf Simonsen, Ole Hilberg, Echocardiographic Screening for Pulmonary Hypertension in Stable COPD Out-Patients and NT-proBNP as a Rule-Out Test COPD: Journal of Chronic Obstructive Pulmonary Disease. ,vol. 9, pp. 505- 512 ,(2012) , 10.3109/15412555.2012.695818
Mario Malerba, Alessandro Radaeli, Beatrice Ragnoli, Paolo Airo', Massimo Corradi, Antonio Ponticiello, Alberto Zambruni, Vittorio Grassi, Exhaled Nitric Oxide Levels in Systemic Sclerosis With and Without Pulmonary Involvement Chest. ,vol. 132, pp. 575- 580 ,(2007) , 10.1378/CHEST.06-2929
Todor A. Popov, Human exhaled breath analysis. Annals of Allergy Asthma & Immunology. ,vol. 106, pp. 451- 456 ,(2011) , 10.1016/J.ANAI.2011.02.016
Jérôme Le Pavec, Marc Humbert, Luc Mouthon, Paul M. Hassoun, Systemic Sclerosis-associated Pulmonary Arterial Hypertension American Journal of Respiratory and Critical Care Medicine. ,vol. 181, pp. 1285- 1293 ,(2010) , 10.1164/RCCM.200909-1331PP
Arthur Filusch, Evangelos Giannitsis, Hugo A. Katus, Franz J. Meyer, High-sensitive troponin T: a novel biomarker for prognosis and disease severity in patients with pulmonary arterial hypertension. Clinical Science. ,vol. 119, pp. 207- 213 ,(2010) , 10.1042/CS20100014
Adam Torbicki, Marcin Kurzyna, Paweł Kuca, Anna Fijałkowska, Jarosław Sikora, Michał Florczyk, Piotr Pruszczyk, Janusz Burakowski, Lilianna Wawrzyńska, Detectable Serum Cardiac Troponin T as a Marker of Poor Prognosis Among Patients With Chronic Precapillary Pulmonary Hypertension Circulation. ,vol. 108, pp. 844- 848 ,(2003) , 10.1161/01.CIR.0000084544.54513.E2
Jens Peter Goetze, Regitze Videbaek, Soren Boesgaard, Jan Aldershvile, Jens F Rehfeld, Jorn Carlsen, Pro-brain natriuretic peptide as marker of cardiovascular or pulmonary causes of dyspnea in patients with terminal parenchymal lung disease. Journal of Heart and Lung Transplantation. ,vol. 23, pp. 80- 87 ,(2004) , 10.1016/S1053-2498(03)00060-3